In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deerfield Management Opts For More Private Investment And A New Public Face

Executive Summary

Deerfield Management, the $3.5 billion health care hedge fund, is aggressively expanding its investments in private life sciences companies. As many VCs continue to struggle raising new funds Deerfield hopes its shift, combined with a flexible, research-driven approach to investing and a new involvement in the civic and academic activities shaping the sector, will secure its position as a top health care financier.

Advertisement

Related Content

Arbor's Bid For XenoPort Likely Driven By Effort To Grow Horizant
Deerfield’s Private Designs
Spectrum Bets On Marqibo In NHL With Low-Priced Talon Acquisition
When To Hold ’Em: Post-IPO, VCs Keep Their Cards
Device/Diagnostics Quarterly Deal Statistics, Q1 2013
The Future Of Private Biotech Investment: A Q&A With Jonathan Leff
Cometriq Thyroid Approval May Open Door For Use In Prostate Cancer
Deerfield To NitroMed: Not So Fast, Not So Cheap

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel